Fondaparinux: Pharmacology and Clinical Experience in Cardiovascular Medicine

Author(s): V. Toschi , M. Lettino .

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 7 , Issue 4 , 2007

Become EABM
Become Reviewer

Abstract:

Fondaparinux is a synthetic, five-saccharide chain, AT-dependent, anti-FXa agent. Studies showed that fondaparinux acts in prevention and treatment of venous thromboembolism and in ischemic heart disease, without significant bleeding risk. The drug inhibits thrombin generation, has long half-life and can be administered once-daily without laboratory monitoring. It may be used in HIT treatment.

Keywords: Antithrombotic, factor Xa inhibitor, heparin, low molecular weight heparin, fondaparinux

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 4
Year: 2007
Page: [383 - 387]
Pages: 5
DOI: 10.2174/138955707780363819
Price: $58

Article Metrics

PDF: 3